Literature DB >> 22543615

Seroprevalence of anti-Toxoplasma gondii IgG antibody in patients with schizophrenia.

O Emelia1, R N Amal, Z Z Ruzanna, H Shahida, Z Azzubair, K S Tan, S Noor Aadila, N A M Siti, M Y Aisah.   

Abstract

Schizophrenia is a pervasive neuropsychiatric disease of unknown cause. Previous studies have reported that toxoplasmosis may be a possible cause of schizophrenia. To ascertain possible relationship between Toxoplasma gondii and schizophrenia, a cross sectional study, employing an enzyme-linked immunosorbent assay (ELISA) was performed to study the seroprevalence of anti-T. gondii IgG antibody in schizophrenic patients. Furthermore, demographic data analysis from schizophrenic patients were analysed to associate toxoplasmosis with schizophrenia. A total of 288 serum samples from schizophrenic patients (n=144) and psychiatrically healthy volunteers (n=144) were recruited in this study. Interestingly, a significant result in the serointensity rate of anti-T. gondii IgG antibody (> 60 IU/mL) in schizophrenic patients (61.1%) was demonstrated as compared to psychiatrically healthy volunteers (40.8%) (X² = 4.236, p < 0.050). However, there was no significant difference between the seropositivity rate of anti-T. gondii IgG antibody between the two groups. Analysis from demographic data revealed that the seropositivity rate of anti-T. gondii IgG antibody in schizophrenic patients was significantly associated with age group of more than 40 years old (p=0.007) and between ethnic (p=0.046). Nevertheless, no significant association between seropositivity rate of anti-T. gondii IgG antibody with gender (p=0.897), duration of illness (p=0.344) and family history of schizophrenia (p=0.282) in these patients. Thus, this finding is essential as a preliminary data in Malaysia to establish the association between T. gondii and schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22543615

Source DB:  PubMed          Journal:  Trop Biomed        ISSN: 0127-5720            Impact factor:   0.623


  11 in total

Review 1.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

2.  Association between Toxoplasma gondii seropositivity and memory function in nondemented older adults.

Authors:  Cynthia P Wyman; Shawn D Gale; Ariana Hedges-Muncy; Lance D Erickson; Eric Wilson; Dawson W Hedges
Journal:  Neurobiol Aging       Date:  2017-02-03       Impact factor: 4.673

3.  Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate.

Authors:  Guillaume Fond; Alexandra Macgregor; Ryad Tamouza; Nora Hamdani; Alexandre Meary; Marion Leboyer; Jean-Francois Dubremetz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-06-15       Impact factor: 5.270

4.  Seroepidemiology of Toxoplasmosis among People Having Close Contact with Animals.

Authors:  Guo-Jie Brandon-Mong; Nurul Asma Anati Che Mat Seri; Reuben Sunil-Kumar Sharma; Hemah Andiappan; Tian-Chye Tan; Yvonne Ai-Lian Lim; Veeranoot Nissapatorn
Journal:  Front Immunol       Date:  2015-04-28       Impact factor: 7.561

Review 5.  Gender identity disorder and schizophrenia: neurodevelopmental disorders with common causal mechanisms?

Authors:  Ravi Philip Rajkumar
Journal:  Schizophr Res Treatment       Date:  2014-12-04

6.  Associations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries.

Authors:  Labanté Outcha Daré; Pierre-Emile Bruand; Daniel Gérard; Benoît Marin; Valerie Lameyre; Farid Boumédiène; Pierre-Marie Preux
Journal:  BMC Public Health       Date:  2019-12-05       Impact factor: 3.295

Review 7.  Seroprevalence of ToRCH Pathogens in Southeast Asia.

Authors:  Franziska E Fuchs; Maude Pauly; Antony P Black; Judith M Hübschen
Journal:  Microorganisms       Date:  2021-03-11

8.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

9.  SEROPREVALENCE AND RISK FACTOR OF TOXOPLASMOSIS IN SCHIZOPHRENIA PATIENTS REFERRED TO GRHASIA PSYCHIATRIC HOSPITAL, YOGYAKARTA, INDONESIA.

Authors:  Nina Difla Muflikhah; Wayan Tunas Artama
Journal:  Afr J Infect Dis       Date:  2018-03-07

10.  Toxoplasmosis Is More Frequent in Schizophrenia Patients Than in the General Population in Mexico and Is Not Associated with More Severe Course of Schizophrenia Measured with the Brief Psychiatric Rating Scale.

Authors:  María de la Luz Galván-Ramírez; Gabriela Navarro Machuca; Sergio Armando Covarrubias Castillo; Juan Carlos Benavides González; Laura Roció Rodríguez Pérez; Sergio Horacio Dueñas Jiménez; Judith Marcela Dueñas Jiménez
Journal:  Pathogens       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.